Correlation Between ATyr Pharma and G1 Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and G1 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and G1 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and G1 Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and G1 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of G1 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and G1 Therapeutics.
Diversification Opportunities for ATyr Pharma and G1 Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between ATyr and GTHX is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and G1 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on G1 Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with G1 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of G1 Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and G1 Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and G1 Therapeutics
If you would invest 715.00 in G1 Therapeutics on September 5, 2024 and sell it today you would earn a total of 0.00 from holding G1 Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ATyr Pharma vs. G1 Therapeutics
Performance |
Timeline |
ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
G1 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
ATyr Pharma and G1 Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATyr Pharma and G1 Therapeutics
The main advantage of trading using opposite ATyr Pharma and G1 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, G1 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in G1 Therapeutics will offset losses from the drop in G1 Therapeutics' long position.ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
G1 Therapeutics vs. Allogene Therapeutics | G1 Therapeutics vs. Heron Therapeuti | G1 Therapeutics vs. Annexon | G1 Therapeutics vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |